This document discusses a case of alcoholic liver disease being investigated by Dr. N. Gautam. It provides background information on liver anatomy, alcohol metabolism, and the pathophysiology and clinical presentations of alcoholic liver disease. It describes the typical laboratory investigations performed for ALD including liver enzymes, bilirubin, proteins, and coagulation factors. The document then presents findings from a 45-year-old chronic alcoholic male patient presenting with abdominal pain, jaundice and altered sensorium, with laboratory results consistent with severe alcoholic hepatitis.
Chronic excessive alcohol consumption can lead to a spectrum of alcoholic liver disease including fatty liver, alcoholic hepatitis, and cirrhosis. Fatty liver is most common, while only 10-20% of alcoholics develop hepatitis. Hepatitis is characterized by hepatocyte injury, ballooning, and inflammation. Cirrhosis results in fibrosis and nodular regeneration of liver architecture. Complications include ascites, variceal bleeding, and hepatic encephalopathy. Treatment of alcoholic liver disease involves abstaining from alcohol and managing complications. Corticosteroids may benefit severe hepatitis. Liver transplantation is an option for end-stage disease if abstinence is maintained.
This document discusses alcoholic liver disease (ALD). It notes that ALD ranges in severity from fatty liver to alcoholic hepatitis to cirrhosis. Risk factors include the amount of alcohol consumed daily and genetically. Diagnosis involves blood tests like GGT and liver biopsy. Severe alcoholic hepatitis has high short-term mortality and is treated with corticosteroids or pentoxifylline to reduce inflammation. Prognosis can be predicted using scores like Maddrey DF and management involves lifestyle changes like abstaining from alcohol and adequate nutrition.
This document discusses alcoholic liver disease. It begins by defining alcoholic liver disease as damage to the liver caused by alcohol abuse over many years of heavy drinking. Not all heavy drinkers will develop liver disease, but the risk increases with longer and heavier drinking. Symptoms may include fatigue, poor appetite, nausea, jaundice, and confusion. The document then presents a case study of a 55-year-old male patient with alcoholic liver disease symptoms and test results indicating liver damage. It outlines the patient's treatment plan and medications to support liver function recovery. Finally, it provides lifestyle recommendations to prevent alcoholic liver disease, such as avoiding alcohol, eating a healthy diet, and engaging in regular physical activity.
Case presentation on Alcoholic liver diseaseHAMMADKC
A 60-year old male patient presented with complaints of yellowish skin discoloration, swelling in the lower legs, constipation, abdominal distension, and fatigue. He had a history of alcohol use for 8 years and smoking for 12 years. Laboratory tests showed elevated bilirubin levels and liver enzymes. An ultrasound revealed a fatty liver with surface nodules. He was diagnosed with alcoholic liver disease and treated with medications, lifestyle counseling, and advised to abstain from alcohol and smoking. His symptoms improved over three days of treatment and he was discharged.
SYSTEMATIC APPROACH TO LIVER FUNCTION TEST
BY Dr. Navas Shareef. P.P (MBBS)
THIS PRESENTATION IS MADE IN A SIMPLIFIED FORM SO THAT EVERYONE COULD UNDERSTAND ABOUT A LIVER FUNCTION TEST EASILY
Chronic excessive alcohol consumption can lead to a spectrum of alcoholic liver disease including fatty liver, alcoholic hepatitis, and cirrhosis. Fatty liver is most common, while only 10-20% of alcoholics develop hepatitis. Hepatitis is characterized by hepatocyte injury, ballooning, and inflammation. Cirrhosis results in fibrosis and nodular regeneration of liver architecture. Complications include ascites, variceal bleeding, and hepatic encephalopathy. Treatment of alcoholic liver disease involves abstaining from alcohol and managing complications. Corticosteroids may benefit severe hepatitis. Liver transplantation is an option for end-stage disease if abstinence is maintained.
This document discusses alcoholic liver disease (ALD). It notes that ALD ranges in severity from fatty liver to alcoholic hepatitis to cirrhosis. Risk factors include the amount of alcohol consumed daily and genetically. Diagnosis involves blood tests like GGT and liver biopsy. Severe alcoholic hepatitis has high short-term mortality and is treated with corticosteroids or pentoxifylline to reduce inflammation. Prognosis can be predicted using scores like Maddrey DF and management involves lifestyle changes like abstaining from alcohol and adequate nutrition.
This document discusses alcoholic liver disease. It begins by defining alcoholic liver disease as damage to the liver caused by alcohol abuse over many years of heavy drinking. Not all heavy drinkers will develop liver disease, but the risk increases with longer and heavier drinking. Symptoms may include fatigue, poor appetite, nausea, jaundice, and confusion. The document then presents a case study of a 55-year-old male patient with alcoholic liver disease symptoms and test results indicating liver damage. It outlines the patient's treatment plan and medications to support liver function recovery. Finally, it provides lifestyle recommendations to prevent alcoholic liver disease, such as avoiding alcohol, eating a healthy diet, and engaging in regular physical activity.
Case presentation on Alcoholic liver diseaseHAMMADKC
A 60-year old male patient presented with complaints of yellowish skin discoloration, swelling in the lower legs, constipation, abdominal distension, and fatigue. He had a history of alcohol use for 8 years and smoking for 12 years. Laboratory tests showed elevated bilirubin levels and liver enzymes. An ultrasound revealed a fatty liver with surface nodules. He was diagnosed with alcoholic liver disease and treated with medications, lifestyle counseling, and advised to abstain from alcohol and smoking. His symptoms improved over three days of treatment and he was discharged.
SYSTEMATIC APPROACH TO LIVER FUNCTION TEST
BY Dr. Navas Shareef. P.P (MBBS)
THIS PRESENTATION IS MADE IN A SIMPLIFIED FORM SO THAT EVERYONE COULD UNDERSTAND ABOUT A LIVER FUNCTION TEST EASILY
CASE PRESENTATION ON obstructive jaundice Naresh sah
The document provides a case presentation on obstructive jaundice in a 43-year-old male patient. It includes demographic details, medical history, subjective and objective evidence from examinations and lab reports, medications, progress notes, assessments, care plan, pharmacist interventions, and patient education. The assessments determined the patient had obstructive jaundice likely due to periampullary carcinoma. Treatment included antibiotics, analgesics, vitamins, and surgery to remove the tumor, with the goals of reducing fever, itching, and jaundice which were achieved.
A 55-year-old male presented with jaundice, decreased urination, and swelling of the body for 1 month. He has a history of alcoholism and smoking for 3 years. Laboratory tests revealed elevated bilirubin, liver enzymes, and signs of portal hypertension. He was diagnosed with alcoholic liver disease. Treatment included medications to protect the liver, manage complications, and lifestyle changes like abstaining from alcohol. Due to his condition, consultation with nutrition, gastroenterology, nephrology, neurology, and infectious disease services was recommended. Immunization against common liver pathogens and lifestyle modifications were also advised to prevent further damage and support recovery.
Alcoholic liver disease is a term that encompasses the hepatic manifestations of alcohol overconsumption, including fatty liver, alcoholic hepatitis, and chronic hepatitis with hepatic fibrosis or cirrhosis.
This document provides an overview of jaundice and an approach to evaluating a patient presenting with jaundice. It discusses bilirubin metabolism and liver function tests that can help determine if the cause is pre-hepatic, hepatocellular, or cholestatic in nature. A careful history, physical exam, and lab tests are important to identify potential etiologies and decide if further radiological or biopsy evaluation is needed. The liver function tests and their patterns of elevation can help localize the site of pathology as hepatocellular or cholestatic liver disease.
This document provides information on the clinical management of a patient presenting with jaundice. It begins by defining jaundice and explaining bilirubin metabolism. Jaundice is classified by the type of circulating bilirubin (conjugated or unconjugated) and site of the problem (prehepatic, hepatocellular, or cholestatic/obstructive). The causes, clinical manifestations, appropriate laboratory tests, and imaging studies are described for each type of jaundice to aid in diagnosis and management. A thorough history, physical exam, and targeted lab and imaging workup are recommended to determine the underlying etiology causing a patient's jaundice.
1) Alcoholic hepatitis is caused by chronic excessive alcohol ingestion and can lead to fatty liver, alcoholic hepatitis, or alcoholic cirrhosis. Risk increases with more than 60-80 g of alcohol per day for 10 years in men or 20-40 g per day for 10 years in women.
2) Alcoholic hepatitis presents with fever, jaundice, abdominal pain, and muscle wasting. Liver tests show elevated AST and ALT levels and AST:ALT ratio over 2. Treatment involves alcohol abstinence, nutrition support, corticosteroids or pentoxifylline, and liver transplantation may be considered.
3) Drug-induced hepatitis can occur through direct toxicity or idiosyncratic reactions.
The patient, an 18-year-old male, presented with fever, abdominal pain, cough, increased thirst, yellowish discoloration of eyes, and high colored urine for 4 days. Laboratory tests confirmed viral hepatitis with elevated liver enzymes and IgM antibodies positive. He was diagnosed and treated conservatively for viral hepatitis over 7 days of hospitalization with supportive care and medications to reduce symptoms and prevent complications. Upon discharge, he was counselled on medication compliance, disease education, and lifestyle modifications including improved sanitization, food safety, and immunization.
This document discusses alcoholic liver disease (ALD). It begins by defining ALD and its stages - fatty liver, alcoholic hepatitis, and cirrhosis. It then discusses risk factors like gender, genetics, and drinking patterns. Symptoms for each stage are provided. The pathophysiology of steatosis, hepatitis, and cirrhosis are explained. Diagnostic tests including blood tests, imaging, and biopsy are outlined. Management of ALD focuses on abstinence, nutrition, medications to prevent complications, and potentially transplantation for late-stage disease.
Alcoholic liver disease progresses through three main stages - steatosis (fatty liver), alcoholic hepatitis, and cirrhosis. Steatosis is reversible with abstinence and is characterized by fat accumulation in hepatocytes without fibrosis. Alcoholic hepatitis involves necrosis and inflammation in addition to steatosis, with clinical findings including jaundice. Cirrhosis is the irreversible last stage, where liver fibrosis and nodular transformation leads to liver failure and increased risk of liver cancer. Management involves abstinence from alcohol and nutritional support, with corticosteroids and liver transplantation used in later stages.
Alcoholic liver disease is caused by overconsumption of alcohol which damages the liver. It ranges from fatty liver to alcoholic hepatitis and cirrhosis. Symptoms vary depending on the stage of disease. Diagnosis involves liver function tests, imaging and biopsy. Complications include portal hypertension, ascites, and hepatic encephalopathy. Treatment focuses on abstinence from alcohol, nutrition supplementation to address deficiencies, medications for complications, and liver transplantation in severe cases.
This document summarizes two case studies of pediatric patients referred for hypercholesterolemia screening and management. Case 1 involves a 14-year-old male with a total cholesterol of 286 mg/dl referred due to his father's hypercholesterolemia. His diet and lifestyle are assessed. Case 2 involves an 11-year-old male with a total cholesterol of 250 mg/dl referred after his father had a myocardial infarction and was found to have hypercholesterolemia. His diet consists of fast food and snacks. Guidelines for pediatric cholesterol screening and dietary and lifestyle interventions are reviewed.
1. A 35-year-old male was admitted to the hospital with abdominal pain and nausea and was diagnosed with acute pancreatitis based on elevated serum amylase and lipase levels and abdominal ultrasound findings.
2. He was treated with IV fluids, pantoprazole, ondansetron, tramadol, thiamine injections, and later ceftriaxone injections. His condition was monitored over three days and showed improvement.
3. Acute pancreatitis can be caused by gallstones, heavy alcohol use, certain medications, and other factors. It leads to inflammation of the pancreas and pain in the upper abdomen. Treatment focuses on pain relief, rehydration, and addressing the
This document provides an overview of evaluating and diagnosing liver disease. It discusses classifying liver diseases as hepatocellular, cholestatic, or mixed based on etiology and evaluating disease severity and stage. Common symptoms, diagnostic tests, clinical findings, and classifications such as Child-Pugh staging for cirrhosis are outlined.
DILI is possible consequence of ingestion of OTC drugs like PCM.
so it require careful clinical knowledge before taking drugs without doctors prescriptions...
Alcohol consumption can lead to various liver diseases known as alcoholic liver disease (ALD). Chronic heavy drinking is responsible for 50% of chronic liver disease cases in India. Symptoms of ALD may not appear until the disease is advanced and include fatigue, abdominal swelling and pain, and jaundice. Alcohol is metabolized in the liver, producing reactive oxygen species that can cause oxidative stress, fatty liver, inflammation, fibrosis and eventually cirrhosis over many years. Diagnosis involves assessing drinking history, symptoms, lab tests and biopsy. Treatment focuses on abstaining from alcohol. Corticosteroids and antioxidants may help in some cases. Liver transplantation is an option for end-stage ALD but is not usually recommended for
This document contains information about a case study of a 65-year-old male patient presenting with fever, cough, abdominal pain, chest pain, body pain and weight loss. He was diagnosed with chronic obstructive pulmonary disease (COPD) based on his symptoms and investigation results. He was treated according to the standard COPD treatment protocol with antibiotics, bronchodilators, mucolytics and lifestyle modifications. The pharmacist found the prescription to be rational and counselled the patient about his disease, medications and lifestyle changes.
A blockage of blood flow to the heart muscle. A heart attack is a medical emergency.A heart attack usually occurs when a blood clot blocks blood flow to the heart.Without blood,tissues loses oxygen and dies
clinical approach to jaundice in adultsReem Alyahya
A 66-year-old man presented with yellowish discoloration of his eyes and itching over the past 3 months. He also reported an unintentional 10 kg weight loss and physical examination found a palpable mass in his right upper abdomen. Evaluation for jaundice includes history, physical exam, liver enzymes, imaging and other tests based on suspected etiology. In this case, the patient's symptoms suggest biliary obstruction caused by pancreatic cancer given his age, weight loss, abdominal mass and minimal itching.
UTIs are common infections, especially in women. This patient presented with fever, chills, headache, body ache and vomiting for 7 days. Examination found fever. Urine tests found pus cells. The patient was diagnosed with a urinary tract infection and treated with IV antibiotics, antipyretics, pantoprazole and vitamins. Symptoms improved and the patient was discharged after 5 days with oral antibiotics and other medications. However, prescribing lariago without a positive malaria test was irrational.
1.Detect presence of liver disease.
2.Distinguish among different types of liver diseases.
3.Estimate the extent of known liver damage.
4.Follow the response of treatment
Chronic and excessive alcohol consumption can lead to a spectrum of alcoholic liver disease (ALD) ranging from fatty liver to cirrhosis. The risk and severity increases with the amount of alcohol consumed daily over many years. Diagnosis involves documenting a history of heavy drinking and liver-related abnormalities. Treatment focuses on abstinence to prevent progression of disease. Corticosteroids may help severe alcoholic hepatitis while liver transplantation is an option for end-stage cirrhosis. Long-term management involves screening for complications and lifestyle changes to support abstinence and liver health.
CASE PRESENTATION ON obstructive jaundice Naresh sah
The document provides a case presentation on obstructive jaundice in a 43-year-old male patient. It includes demographic details, medical history, subjective and objective evidence from examinations and lab reports, medications, progress notes, assessments, care plan, pharmacist interventions, and patient education. The assessments determined the patient had obstructive jaundice likely due to periampullary carcinoma. Treatment included antibiotics, analgesics, vitamins, and surgery to remove the tumor, with the goals of reducing fever, itching, and jaundice which were achieved.
A 55-year-old male presented with jaundice, decreased urination, and swelling of the body for 1 month. He has a history of alcoholism and smoking for 3 years. Laboratory tests revealed elevated bilirubin, liver enzymes, and signs of portal hypertension. He was diagnosed with alcoholic liver disease. Treatment included medications to protect the liver, manage complications, and lifestyle changes like abstaining from alcohol. Due to his condition, consultation with nutrition, gastroenterology, nephrology, neurology, and infectious disease services was recommended. Immunization against common liver pathogens and lifestyle modifications were also advised to prevent further damage and support recovery.
Alcoholic liver disease is a term that encompasses the hepatic manifestations of alcohol overconsumption, including fatty liver, alcoholic hepatitis, and chronic hepatitis with hepatic fibrosis or cirrhosis.
This document provides an overview of jaundice and an approach to evaluating a patient presenting with jaundice. It discusses bilirubin metabolism and liver function tests that can help determine if the cause is pre-hepatic, hepatocellular, or cholestatic in nature. A careful history, physical exam, and lab tests are important to identify potential etiologies and decide if further radiological or biopsy evaluation is needed. The liver function tests and their patterns of elevation can help localize the site of pathology as hepatocellular or cholestatic liver disease.
This document provides information on the clinical management of a patient presenting with jaundice. It begins by defining jaundice and explaining bilirubin metabolism. Jaundice is classified by the type of circulating bilirubin (conjugated or unconjugated) and site of the problem (prehepatic, hepatocellular, or cholestatic/obstructive). The causes, clinical manifestations, appropriate laboratory tests, and imaging studies are described for each type of jaundice to aid in diagnosis and management. A thorough history, physical exam, and targeted lab and imaging workup are recommended to determine the underlying etiology causing a patient's jaundice.
1) Alcoholic hepatitis is caused by chronic excessive alcohol ingestion and can lead to fatty liver, alcoholic hepatitis, or alcoholic cirrhosis. Risk increases with more than 60-80 g of alcohol per day for 10 years in men or 20-40 g per day for 10 years in women.
2) Alcoholic hepatitis presents with fever, jaundice, abdominal pain, and muscle wasting. Liver tests show elevated AST and ALT levels and AST:ALT ratio over 2. Treatment involves alcohol abstinence, nutrition support, corticosteroids or pentoxifylline, and liver transplantation may be considered.
3) Drug-induced hepatitis can occur through direct toxicity or idiosyncratic reactions.
The patient, an 18-year-old male, presented with fever, abdominal pain, cough, increased thirst, yellowish discoloration of eyes, and high colored urine for 4 days. Laboratory tests confirmed viral hepatitis with elevated liver enzymes and IgM antibodies positive. He was diagnosed and treated conservatively for viral hepatitis over 7 days of hospitalization with supportive care and medications to reduce symptoms and prevent complications. Upon discharge, he was counselled on medication compliance, disease education, and lifestyle modifications including improved sanitization, food safety, and immunization.
This document discusses alcoholic liver disease (ALD). It begins by defining ALD and its stages - fatty liver, alcoholic hepatitis, and cirrhosis. It then discusses risk factors like gender, genetics, and drinking patterns. Symptoms for each stage are provided. The pathophysiology of steatosis, hepatitis, and cirrhosis are explained. Diagnostic tests including blood tests, imaging, and biopsy are outlined. Management of ALD focuses on abstinence, nutrition, medications to prevent complications, and potentially transplantation for late-stage disease.
Alcoholic liver disease progresses through three main stages - steatosis (fatty liver), alcoholic hepatitis, and cirrhosis. Steatosis is reversible with abstinence and is characterized by fat accumulation in hepatocytes without fibrosis. Alcoholic hepatitis involves necrosis and inflammation in addition to steatosis, with clinical findings including jaundice. Cirrhosis is the irreversible last stage, where liver fibrosis and nodular transformation leads to liver failure and increased risk of liver cancer. Management involves abstinence from alcohol and nutritional support, with corticosteroids and liver transplantation used in later stages.
Alcoholic liver disease is caused by overconsumption of alcohol which damages the liver. It ranges from fatty liver to alcoholic hepatitis and cirrhosis. Symptoms vary depending on the stage of disease. Diagnosis involves liver function tests, imaging and biopsy. Complications include portal hypertension, ascites, and hepatic encephalopathy. Treatment focuses on abstinence from alcohol, nutrition supplementation to address deficiencies, medications for complications, and liver transplantation in severe cases.
This document summarizes two case studies of pediatric patients referred for hypercholesterolemia screening and management. Case 1 involves a 14-year-old male with a total cholesterol of 286 mg/dl referred due to his father's hypercholesterolemia. His diet and lifestyle are assessed. Case 2 involves an 11-year-old male with a total cholesterol of 250 mg/dl referred after his father had a myocardial infarction and was found to have hypercholesterolemia. His diet consists of fast food and snacks. Guidelines for pediatric cholesterol screening and dietary and lifestyle interventions are reviewed.
1. A 35-year-old male was admitted to the hospital with abdominal pain and nausea and was diagnosed with acute pancreatitis based on elevated serum amylase and lipase levels and abdominal ultrasound findings.
2. He was treated with IV fluids, pantoprazole, ondansetron, tramadol, thiamine injections, and later ceftriaxone injections. His condition was monitored over three days and showed improvement.
3. Acute pancreatitis can be caused by gallstones, heavy alcohol use, certain medications, and other factors. It leads to inflammation of the pancreas and pain in the upper abdomen. Treatment focuses on pain relief, rehydration, and addressing the
This document provides an overview of evaluating and diagnosing liver disease. It discusses classifying liver diseases as hepatocellular, cholestatic, or mixed based on etiology and evaluating disease severity and stage. Common symptoms, diagnostic tests, clinical findings, and classifications such as Child-Pugh staging for cirrhosis are outlined.
DILI is possible consequence of ingestion of OTC drugs like PCM.
so it require careful clinical knowledge before taking drugs without doctors prescriptions...
Alcohol consumption can lead to various liver diseases known as alcoholic liver disease (ALD). Chronic heavy drinking is responsible for 50% of chronic liver disease cases in India. Symptoms of ALD may not appear until the disease is advanced and include fatigue, abdominal swelling and pain, and jaundice. Alcohol is metabolized in the liver, producing reactive oxygen species that can cause oxidative stress, fatty liver, inflammation, fibrosis and eventually cirrhosis over many years. Diagnosis involves assessing drinking history, symptoms, lab tests and biopsy. Treatment focuses on abstaining from alcohol. Corticosteroids and antioxidants may help in some cases. Liver transplantation is an option for end-stage ALD but is not usually recommended for
This document contains information about a case study of a 65-year-old male patient presenting with fever, cough, abdominal pain, chest pain, body pain and weight loss. He was diagnosed with chronic obstructive pulmonary disease (COPD) based on his symptoms and investigation results. He was treated according to the standard COPD treatment protocol with antibiotics, bronchodilators, mucolytics and lifestyle modifications. The pharmacist found the prescription to be rational and counselled the patient about his disease, medications and lifestyle changes.
A blockage of blood flow to the heart muscle. A heart attack is a medical emergency.A heart attack usually occurs when a blood clot blocks blood flow to the heart.Without blood,tissues loses oxygen and dies
clinical approach to jaundice in adultsReem Alyahya
A 66-year-old man presented with yellowish discoloration of his eyes and itching over the past 3 months. He also reported an unintentional 10 kg weight loss and physical examination found a palpable mass in his right upper abdomen. Evaluation for jaundice includes history, physical exam, liver enzymes, imaging and other tests based on suspected etiology. In this case, the patient's symptoms suggest biliary obstruction caused by pancreatic cancer given his age, weight loss, abdominal mass and minimal itching.
UTIs are common infections, especially in women. This patient presented with fever, chills, headache, body ache and vomiting for 7 days. Examination found fever. Urine tests found pus cells. The patient was diagnosed with a urinary tract infection and treated with IV antibiotics, antipyretics, pantoprazole and vitamins. Symptoms improved and the patient was discharged after 5 days with oral antibiotics and other medications. However, prescribing lariago without a positive malaria test was irrational.
1.Detect presence of liver disease.
2.Distinguish among different types of liver diseases.
3.Estimate the extent of known liver damage.
4.Follow the response of treatment
Chronic and excessive alcohol consumption can lead to a spectrum of alcoholic liver disease (ALD) ranging from fatty liver to cirrhosis. The risk and severity increases with the amount of alcohol consumed daily over many years. Diagnosis involves documenting a history of heavy drinking and liver-related abnormalities. Treatment focuses on abstinence to prevent progression of disease. Corticosteroids may help severe alcoholic hepatitis while liver transplantation is an option for end-stage cirrhosis. Long-term management involves screening for complications and lifestyle changes to support abstinence and liver health.
Liver Dialogue for Gynaecologists : Dr Sharda JainLifecare Centre
This document discusses the functions of the liver and various liver function tests. It notes that the liver has important metabolic, excretory, protective, hematological, synthetic and storage functions. It then describes several common liver function tests including SGPT, SGOT, GGT, ALP, bilirubin, total protein, albumin, PT, bleeding time and clotting time. It provides details on the clinical significance, normal ranges and potential causes of interference for each of these tests. The document emphasizes that liver function tests can help screen for and diagnose liver dysfunction, assess prognosis, and monitor response to therapy.
The document provides information on various liver function tests (LFTs). It discusses the purpose and classification of LFTs and describes the normal ranges and clinical significance of increased or decreased levels for specific enzymes and proteins measured in LFTs, including bilirubin, ALT, AST, alkaline phosphatase, gamma-glutamyl transferase, and 5' nucleotidase. Abnormal levels can indicate liver inflammation or injury from various causes like viruses, drugs, or cancer. LFTs are important for diagnosing and monitoring liver diseases.
The document discusses the normal physiological functions of the liver related to metabolism, digestion, detoxification, and excretion. It then evaluates various biochemical tests used to assess abnormal liver function in liver disorders, including tests related to bilirubin metabolism, bile salts, synthetic function, and enzyme levels. Finally, it discusses the approach to specific liver disorders like cirrhosis and viral hepatitis.
Abnormal liver function tests can indicate underlying liver disease but may also be caused by extrahepatic factors. A thorough evaluation is needed and includes considering the pattern of test abnormalities, severity of changes, and potential etiologies. For hepatocellular predominant abnormalities, further workup may include tests for viral hepatitis, autoimmune disease, and iron overload. Liver biopsy may be needed if initial testing is unrevealing. Proper diagnosis guides management and treatment of underlying liver conditions.
1. The document discusses factors to consider when prescribing psychiatric medications in patients with liver disease. Liver disease can impact the pharmacokinetics of drugs by altering absorption, metabolism, protein binding, and excretion.
2. Drugs are categorized based on their hepatic extraction ratio and metabolism. High extraction drugs are more susceptible to fluctuations. Interactions with liver enzyme inducers/inhibitors and alcohol are also discussed.
3. When prescribing for patients with liver disease, the degree of impairment, drug metabolism pathway, interactions, and narrow therapeutic index drugs should be considered. Dose adjustments and monitoring are often needed.
This document discusses liver function tests. It describes the various functions of the liver including metabolic, synthetic, secretory, excretory, detoxifying, storage, protective and miscellaneous functions. Liver function tests are indicated to detect and evaluate liver diseases. The tests are classified into groups based on abnormalities in bile pigment metabolism, synthetic function, serum enzyme activities, carbohydrate and lipid metabolism, detoxicating function, excretory function, amino acid catabolism, drug metabolism and markers of hepatic fibrosis. Specific tests are described including those measuring bilirubin, proteins, clotting factors, enzymes and metabolic products. Interpretations of different test results are provided for various liver conditions.
Medical considerations in dental treatment of patients with liver disease. Main types of liver disease, clinical manifestations, lab tests, treatment considerations.
This document discusses organ function tests, specifically focusing on liver function tests (LFTs) and kidney function tests (KFTs). It provides an overview of the major metabolic functions of the liver and kidney, including synthesis of proteins, detoxification, and regulation of water and electrolyte balance. It then describes various biomarkers that are used in LFTs and KFTs to evaluate organ function and detect injury, such as liver enzymes, bilirubin, albumin, and creatinine. The limitations of these tests are also noted.
O.F.T. with liver and kidney functions.pdfALLTIMELUCKY
This document discusses organ function tests, specifically liver function tests (LFTs) and kidney function tests (KFTs). It provides an overview of the major metabolic functions of the liver and kidney, including synthesis of proteins, detoxification, and regulation of water and electrolyte balance. It then describes various biomarkers that are measured in LFTs and KFTs to evaluate organ function and detect injury, such as liver enzymes, bilirubin, albumin, and creatinine. The document emphasizes the importance of these tests but also their limitations in diagnosis.
hepatology for primary practitioners.pptxMithraPrasad3
This document provides information on liver function tests (LFTs) and their use in identifying and monitoring liver disease. It discusses various components of the LFT profile including bilirubin, liver enzymes, alkaline phosphatase, albumin, prothrombin time and INR. Elevations in these values can indicate liver injury or other underlying conditions. Causes of isolated hyperbilirubinemia and elevated alkaline phosphatase are outlined. Interpretation of hepatitis B serology and ultrasonography features of chronic liver disease are also reviewed.
Evaluation of liver function tests pptDhiraj Kumar
The document discusses liver function tests used to evaluate liver disease. It provides details on various tests including:
- Serum bilirubin, which detects liver cell damage and cholestasis. Elevated levels suggest viral or alcoholic hepatitis.
- Liver enzymes like ALT and AST reflect hepatocyte damage, while alkaline phosphatase, GGT, and 5'NT indicate cholestasis.
- Prothrombin time evaluates synthetic function and is a marker of severity in acute liver disease.
- Albumin reflects synthetic capacity but has a long half-life. Prealbumin and coagulation factors are more sensitive markers.
- Transient elastography can stage fibrosis non-invasively
The document discusses liver and kidney function tests. It begins by outlining the major metabolic functions of the liver, including synthesis of proteins and clotting factors, detoxification, storage, and bile production. Causes of liver dysfunction are then described. Key liver function tests are explained, including markers of hepatocellular injury (ALT, AST), cholestasis (ALP, GGT), and liver function (bilirubin, albumin, prothrombin time). Limitations of liver function tests are noted. The document then discusses kidney anatomy and function before explaining tests of kidney function like serum creatinine, urea, and uric acid. Interpretation of creatinine clearance and limitations
Liver function tests (LFTs) evaluate liver health and detect liver damage. LFTs measure enzymes released from damaged liver cells (ALT, AST), synthetic function (albumin, clotting factors), and signs of obstruction (bilirubin, ALP, GGT). Elevations in ALT and AST indicate hepatocyte injury while increased bilirubin, ALP, and GGT suggest cholestasis or blockage of bile flow. LFTs help diagnose liver diseases, determine severity, monitor treatment effectiveness, and assess operative risk or need for transplantation.
The liver performs many essential metabolic functions and is susceptible to various diseases. Liver function tests assess the status of the liver through biomarkers related to bile pigment metabolism, protein synthesis, clotting factor production, carbohydrate processing, and blood ammonia levels. Elevations in enzymes like bilirubin, AST, ALT, and prolongation of prothrombin time can indicate liver injury or disease states like viral hepatitis, cirrhosis, and alcoholic liver disease. A variety of other tests are also used to identify underlying etiologies or complications of liver disease.
Similar to Investigating a case of alcoholic liver disease (20)
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
9. ALD-Clinical features
• In early phases most of the people are asymptomatic and found
accidentally
• In late stages once cirrhosis develops patients present with the
following features
– Jaundice
– Pain abdomen
– Hepatospleenomegaly &/or Ascites
– Vomiting/hematemesis/malena
– Gynaecomastia
– Spider naevi
– Coagulation defects
– Convulsions, Altered sensorium, Coma
11. Aminotransferases
• Most frequently used and specific indicators of hepatocellular
necrosis.
• Types :
1. Aspartate aminotransferase (AST)--- 0-35 IU/L
2. Alanine aminotransferase (ALT)--- 0-45 IU/L
• Level correlates with extent of tissue damage.
12. • AST :
Cytosolic and mitochondrial isoenzymes.
Found in liver, cardiac muscle, kidneys, brain, pancreas,
lungs, leucocytes and red cells.
Less sensitive and specific for the liver.
• ALT :
A Cytosolic enzyme.
Highest concentration in liver.
More specific for liver.
13. 1. Severe (>20 times, 1000 U/L) :
– Severe viral hepatitis
– Drug or toxin induced necrosis
– Circulatory shock
2. Moderate (3-20 times) :
– Acute hepatitis
– Neonatal hepatitis
– Chronic hepatitis
– Autoimmune hepatitis
– Drug induced hepatitis
– Alcoholic hepatitis
– Acute biliary tract obstruction
14. 3. Mild (1-3 times) :
– Sepsis induced neonatal hepatitis
– Extrahepatic biliary atresia
– Cirrhosis, Fatty liver
– Non alcoholic steatohepatitis
– Drug toxicity, Myositis
– Duchenne muscular dystrophy, After vigorous exercise
4. AST:ALT ratio :
– Wilson disease, CLD, ALD : Ratio of >2
– NASH with absence of fibrosis in liver biopsy : Ratio <1
– ALT > AST: Toxic hepatitis, viral hepatitis, chronic active
hepatitis and cholestatic hepatitis
15. 5. Mitochondrial AST : Total AST ratio :
– Characteristically elevated in alcoholic liver disease and
Wilson disease.
6. False low aminotransferase levels :
– Patients on long term hemolysis.
– Uremia.
16. Glutamate Dehydrogenase
• Mitochondrial enzyme.
• Liver, heart, muscle and kidneys.
• In liver highest concentration seen in centrilobular
hepatocytes.
• Normal levels are 0-12 U/L
• Levels elevated in alcoholic hepatitis.
17. Alkaline phosphatase
– Normal range : 30-120 IU/L.
– Family of zinc metaloenzymes with a serine at active centre.
– In liver present on histochemically in the microvilli of the bile
canaliculi and on the sinusoidal surface of hepatocytes.
18.
19. Gamma Glutamyl Transferase
• Hepatocytes and biliary epithelial cells.
• Limited due to lack of specificity.
• Large amounts are found in kidneys, pancreas, liver, intestine
and prostate.
• Values higher in neonates and infants upto 1 year and also
increase after 60 year of life.
• Normal range : <55 U/L in males
<38 U/L in females
20. If ALP raise is in parallel to GGT then the
elevation is due to ALD.
21. Serum Bilirubin
• Endogenous anion derived from hemoglobin degradation from
RBCs.
• Normal bilirubin concentration is 0.3-1 mg/dl.
• Increased bilirubin levels is seen in chronic alcoholics and
severe alcoholic liver disease due to direct toxicity effects over
RBC and splenic sequestration causing excessive RBC
damage.
• Raise in bilirubin concentration is upto 5mg/dl.
22. Serum Proteins
• Tests for proteins in liver disease include
Serum total proteins
Serum albumin
Calculation of albumin/globulin ratio
• Normal levels are
Total proteins 6 to 8 g/dl
Albumin 3.5 to 5 g/dl
A:G ratio 1.2 to 1.5:1
23. Serum Albumin
• Quantitatively most important protein in plasma synthesized by the
liver.
• Serum albumin level is not a reliable indicator of hepatic protein
synthesis in acute liver disease as half life is as long as 20 days.
• Serum levels correlates with prognosis.
• Hypoalbuminemia is not specific for liver disease and may occur.
24. Calculation Of Albumin/Globulin Ratio
• Reversal of A/G ratio occurs due to low albumin and raised
gamma globulins in serum.
• Most common gamma globulins raised in alcoholic liver
disease are Ig A, G, M.
• Used in
– Cirrhosis
– Alcoholic liver disease
– Chronic active hepatitis
25. Prothrombin time
• Liver is major site for synthesis of 11 blood coagulation
proteins : Fibrinogen, prothrombin, labile factor, stable
factor, christmas factor, stuart prower factor, prekallikrein,
and high molecular weight kininogen
• The hepatic synthesis of biologically active forms of
factors II, VII, IX and X requires Vit K.
• The standard method to asses is the one stage prothrombin
time.
26. PARAMETER MILD ALD MODERATE ALD SEVERE ALD
AST
ALT
ALP
GGT
BILIRUBIN
N
ALBUMIN
PROTHROMBIN
TIME
27. Maddrey Discriminant Function
(MDF)
MDF = 4.6 X ( PT- PT Control ) + Plasma
Bilirubin (mg/dl)
• MDF >32 indicates individuals with a high mortality rate and
considered as more sensitive marker in identifying the
prognosis.
28. Model of End Stage Liver Disease Score
(MELD Score)
MELD = 3.78×ln[serum bilirubin (mg/dl)] +
11.2×ln[INR] + 9.57×ln[serum creatinine
(mg/dl)] + 6.43×aetiology
(0: cholestatic or alcoholic, 1- otherwise)
• MELD score >11 considered as more specific in identifying
the prognosis of the disease than MDF.
31. USG & Liver Biopsy
• USG is useful in detecting fatty infilteration of the liver and
determining liver size.
• Demonstration of portal vein flow reversal, ascites and intra
abdominal collaterals in USG indicates serious liver injury
with less potential for complete reversal of liver disease.
• Liver biopsy mainly is used to clarify atypical cases and to
determine the severity of liver disease.
33. Carbohydrate Deficient Transferrin
• Alcohol leads to production of isoforms of transferrin with low
sialic acid content termed as hyposialyl or asialyl or carbohydrate
deficient transferrin.
• Studies proven that CDT is the only test to reliably distinguish
alcoholic hepatitis from non alcoholic fatty liver disease.
• Studies have shown that CDT along with GGT increases the
accuracy of identifying problem drinkers and their prognosis.
• Results are reported as a % of total transferrin as this reduces the
effects of gender & variations in level of transferrin.
< 1.3% - negative
1.3 to 1.6% - inconclusive
>1.7% - positive
34. Apo J or Clusterin Sialylation
(Sialic acid Index)
• It is a highly sialylated protein thought to be involved in the
exchange of lipids between different lipoproteins.
• Sialic acid index of Apo J refers to the ratio of moles of sialic
acid per mole of Apo J protein.
Immuno affinity purification of Apo J
Hydrolysis of sialic acid moieties
Spectrophotometric measurement
35. Apo J or Clusterin Sialylation
(Sialic acid Index)
• Sialic acid index of Apo J levels are reduced with chronic
alcohol intake and they then return to normal levels over a
period of 8 weeks with an approximate half life of 4-5 weeks.
36. Total Sialic acid
• Proposed as a marker for heavy alcohol consumption.
• Chronic alcohol use prevents the glycosylation of many
proteins thus sialic acid levels are found elevated in saliva &
urine.
37. Fatty acid ethyl esters
• Formed in both acute & chronic alcohol intake.
Ethyl glucoronides
• Alcohol metabolites combining with glucoronides.
• EtG in hair considered as long term marker and used in case of
doubtful diagnosis.
38. Serotonin metabolites
(5 HTOL:5 HIAA)
Serotonin
5-HTOL:5-HIAA ratio’s sensitivity & specificity is proportional
to the alcohol intake.
Aldehyde
dehydrogenase
Alcohol
dehydrogenase
Acetaldehyde
Alcohol
5-HIAA
5-HTOL
39. Cytokines
• Various inflammatory markers are studied for sensitivity &
specificity in diagnosing alcoholic liver disease.
• Among various cytokines analysed TGF-β & TNF-α which are
major factors responsible for induction of apoptosis, necrosis
and enhancement of collagen synthesis.
40. Case presentation
45 yr old male who is a chronic alcoholic presented in altered
sensorium to the emergency department.
History given by the attenders person was apparently normal 4
days back developed fever a/w chills and rigors with abdominal
pain and been restless since yesterday complaining no relief of
pain in any posture and in semiconscious state speaking
irrelevantly since evening. No episodes of vomiting/ trauma/
bleeding.
Not k/c/o DM, HTN, Epileptic & Asthmatic.
Chronic alcoholic on abstinence for a week.
41. • O/E semi conscious male moderately built & nourished
Icterus ++ Clubbing +
Vitals PR-80/min BP-102/60mm hg
• PA: soft and tenderness + around umbilicus
clinically no organomegaly detected
no evidence of free fluid
bowel sounds + and normal
• CVS/RS: Normal
42. Parameter Findings
Hb% 10.5
WBC 18,010/cc
MCV 72%
Platelet count 1,00,000/cc
PT (INR) 1.2
Parameter Findings
RBS 70mg%
Total bilirubin 26mg%
Direct 20mg%
Indirect 6mg%
Total protein 5gms%
Albumin 2gms%
Globulin 3gms%
AST/SGOT 194 IU/L
ALT/SGPT 104 IU/L
ALP 73 IU/L
Editor's Notes
Vit k is required for addition of carboxylic acid moieties to the y- position of glutamic acid residues in these proteins.the gamma carboxylation step is post-translational process that allows these proteins to bind to calcium avidly a necessity for them to function as clotting factors